Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

avatar
epsilon Private ID: 181451801
No profile added yet
Follow
    In the company's 3Q (August-October) financial results for the fiscal year ending 2023/1, when sales were 152.81 billion dollars, up 8.7% from the same period last year, and when excluding 3.3 billion 25 million dollars recorded as litigation settlement related expenses, EPS after Noon-GAAP adjustment was 1.50 dollars (4.57 dollars for the same period last year). Both sales and adjusted EPS exceeded market expectations. Sales at existing Walmart stores in the US also increased by 8.2%, which greatly exceeded market expectations. Food sales were strong, and e-commerce increased 16% from the same period, contributing to the overall situation. The average number of purchases at existing stores increased by 2.1%, and the average unit price increased 6.0%, contributing to the increase in sales, existing store sales of membership-based Sam's clubs increased 10.0%, and Sam's Club membership fee revenue increased 8.9%. In terms of profit, foods with low margins were doing well, and operating profit margins declined to 1.8% due to promotion of discounts (same 4.1%). Meanwhile, inventory elimination progressed through expanded discounts, and adjusted operating income increased 4% (6 billion dollars) from the same period.
    In response to solid 3Q results, the company raised its full-year results for the fiscal year ending January 2023. Sales for the fiscal year ending January 2023 are based on exchange headwinds of 4.1 billion dollars...
    Translated
    Walmart (WMT) financial results review and outlook for the 3Q (August-October) fiscal year ending 2023/1
    1
    Meta Platforms (NASDAQ: META), a major social media and metaverse company, announced financial results for the fourth quarter after the market closed. Financial highlights are as follows.
    ● Meta Platforms reported fourth quarter sales of 32.17 billion dollars, down 4% from the same period last year.
    ● Meta Platforms' earnings per share for the fourth quarter were 1.76 dollars, which was lower than the street forecast of 2.22 dollars.
    ● Facebook Daily Active Users (DAU) - On average in December 2022, DAU was 2 billion people, up 4% from the previous year.
    ● Facebook monthly active users (MAU) - MAU was 2.96 billion as of 2022/12/31, up 2% from the previous year.
    ● Costs and expenses - Total costs and expenses were $25.77 billion for the fourth quarter of 2022 and $87.66 billion for the full year, up 22% and 23%, respectively.
    1. Are you satisfied with the current financial results?
    2. What opinions and analyses do you have about this company?
    Translated
    Based on IBES data, earnings for the S&P 500 in Q22 are expected to be 447.1 billion dollars (down 2.2% from the same period last year, down 3.6% from the previous quarter) and revenue of 3.69.7 billion dollars (up 4.1% from the same period, down 0.7% from the previous quarter). Facing a tough macro environment, there is a possibility that this year's earnings season will end disappointing, but that hurdle may be low. In other words, there is a possibility that it will be easier for S&P 500 star companies to surpass lowered expectations if the year continues.
    Leading companies such as Apple, Alphabet, and Amazon have just announced their latest financial results. In Apple's case, quarterly revenue fell 5% from the same period last year to 117.2 billion dollars, and quarterly diluted EPS was 1.88 dollars. Alphabet recorded a growth of just 1% in the fourth quarter of 2022. Amazon surpassed fourth-quarter earnings, but provided light guidance.
    It's very important to look at major companies' financial results, which may affect many investors' confidence and overall market performance. Furthermore, future financial results reports may provide valuable information and create trading opportunities...
    Translated
    Highlights of the fourth quarter earnings season: Amazon and Alphabet
    Apple has announced financial results for the first quarter of fiscal 2023 (ending December 31). Financial highlights are as follows.
    ▶️ Revenue for the first quarter of the fiscal year was $117.2 billion, the company announced on Thursday. Wall Street's forecast is about 121.1 billion dollars.
    ▶️ Earnings per share were 1.88 dollars, which was comparable to the expected average of 1.94 dollars.
    ▶️ Amid a tough macroeconomic environment and drastic supply constraints, iPhone sales fell about 8% to 65.78 billion dollars.
    ▶️ Sales in the rapidly growing service sector increased from 19.52 billion dollars to 20.77 billion dollars.
    ▶️ Sales in Apple's wearables, home, and accessories division declined from 14.7 billion dollars in the same period last year to 13.48 billion dollars, but iPad sales increased from 7.25 billion dollars to 9.4 billion dollars.
    - Are you satisfied with the current financial results?
    - 2. What do you think about this company and how do you analyze it?
    Translated
    In the company's 3Q (July-September) financial results for the fiscal year ending 2022/12, sales fell 6% from the same period last year to 22.64 billion dollars, and adjusted diluted EPS increased 40% to 1.78 dollars, which greatly exceeded market expectations (1.39 dollars). In terms of sales, sales of the novel coronavirus vaccine fell 66% from the same period to 4.4 billion dollars. In addition to delays in delivery of COVID-related products to developed countries resonated, exchange headwinds (about 1 billion dollars) etc. were factors in the decline in sales. Meanwhile, the oral remedy “Paxlovid” for the novel coronavirus vaccine approved at the end of last year was 7.5 billion dollars. Sales excluding COVID-related products only increased 2% from the same period. In terms of profit and loss, the ratio of cost of sales to sales was 26.7%, a decrease of 14.5 percentage points compared to the same period last year. This was due to favorable changes in the sales structure, such as a drastic increase in sales of “Paxlovid” and a decrease in sales of “COMIRNATY.” Research and development expenses only increased slightly, but in addition to cost increases for “Paxlovid” and “COMIRNATY,” net profit only increased 6% due to an increase in provisions for US health insurance reform costs, the elimination of deferred tax refunds, etc.
    22...
    Translated
No more